Concerns rise among smaller drugmakers

The nation’s small- and medium–sized pharmaceutical companies are struggling to survive from leading pharmaceutical firms taking a stronger hold of the local market with a number of blockbuster generic drugs.

Market experts forecasted these companies will face more harsh condition in a couple of years to come and will also likely experience wide-scale restructuring.

Furthermore, a heavy c...